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ABSTRACT 
Transdermal drug delivery system (TDDS) is the topically administered medication, which when applied to the skin, delivers the 
drug through the skin for systemic effect at a predetermined and controlled rate. For the drugs, having short biological half life, 
transdermal drug delivery system is convenient. It overcome the  problems  like the hepatic first pass effect, improves the 
compliance of patients, decreases the administration frequency, and reduce the gastrointestinal side effects , peak and valley levels in 
the blood are avoided. Due to have an advantage of being non-invasive, this delivery has to fulfill some parameters such as high 
potency, better permeability through skin and non-irritation for better compliance. Skin serves as a site of drug application for local 
effect as well as systemic effect. There are wide varieties of drugs for which topical or transdermal is a viable option, skin 
penetration enhancement techniques have been developed for such drugs. There are a number of physical methods to increase drug 
delivery via the skin, many of which require the use of devices and some of which hold the promise to significantly expand the 
spectrum of drugs that can be administered transdermally to include water-soluble molecules and macromolecules. Iontophoresis and 
electroporation represent electrically assisted, physical approaches to enhance delivery of drugs/macromolecules across the stratum 
corneum.  This review highlights the detailed role of physical penetration and describes their mechanism of action. 
Keywords: transdermal drug delivery system, stratum corneum , skin penetration enhancer , physical enhancer , iontophoresis. 
________________________________________________________________________________________________ 
 
INTRODUCTION 
All conventional oral dosage form is required to be 
administered in multiple doses at a particular amount for 
an effective therapy. But it has limitations in case of 
patient showing symptoms of vomiting and diarrhoea 
cannot consume drugs by oral route. It is not suitable in 
cases of unconscious and in-cooperative patients. Some 
other drawbacks are inconvenient administration, 
chances of overdose if administered prior to time 
interval, lack of patient compliance, skip of dose by the 
patient, fluctuation of drug plasma level. Particular 
amount of drug is required for effective therapeutic uses. 
To avoid such complications transdermal drug delivery 
system (TDDS) are designed. Transdermal drug delivery 
system aid to development in delivery of proteins and 
neucleotides as the trend for discovering and designing 
biopharmaceuticals continues improvements in 
transdermal delivery will remain incremental until there 
is wider acceptance of this route of administration within 
the pharmaceutical industry. The main aim of 
transdermal drug delivery system is to provide prolong 
action of the drug with low toxicity and better patient 
compliance and thus reduces the side effects caused by 
oral route. 
Transdermal drug delivery system is the system in which 
the delivery of the active ingredients of a drug occurs 
penetrate through the skin. This system is designed to 
improve the therapeutic efficacy and safety of the drugs 
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because drug delivered through the skin at a 
predetermined and controlled rate. 
In recent years, the use of a number of biophysical 
techniques has aided in our understanding of the nature 
of the stratum corneum barrier and the way in which 
chemicals interact with and influence this structure. A 
better understanding of the interaction of enhancers with 
the stratum corneum and the development of structure 
activity relationships for enhancers will aid in the design 
of enhancers with optimal characteristics and minimal 
toxicity. 
In order to increase the range of drugs available for 
transdermal delivery the use of physical enhancement 
techniques have been developed in an attempt to 
compromise skin barrier function in a reversible manner 
without concomitant skin irritation. Several alternative 
physical methods have emerged to transiently break the 
stratum corneum barrier
1, 2, 3.
. 
The various advantages and disadvantages of 
transdermal drug delivery systems are given below: 
Advantages  
 Drug can be delivered over a long period of time. 
 Avoidance of ‘first-pass’ metabolism of drugs. 
 Adverse effects or therapeutic failures frequently 
associated with intermittent dosing can also be 
avoided.  
  Reduction of fluctuations in plasma levels of drugs, 
Utilization of drug candidates with short half-life 
and low therapeutic index. 
 Maintains stable or constant and controlled blood 
levels for longer period of time. 
 Increased convenience to administer drugs which 
would otherwise require frequent dosing. 
 Ability to discontinue administration by removal of 
the system. 
 Self administration can be done. 
Disadvantages of TDDS 
 Drugs having affinity for both lipophilic and 
hydrophilicphases are used. 
 Drugs in high concentration may cause skin 
irritation. 
 Drugs with very low or high partition coefficient 
fail to reach systemic circulation. 
 Difficult to administer large dose i.e. more than 
10mg/ day. 
  Ionic drugs create problem. 
THE SKIN SITE FOR TRANSDERMAL 
ADMINISTRATION 
The skin, as the largest organ of the body, account for 
more than 10% of body mass  and receives about one 
third of the blood circulating through the body , serves 
as a protective layer of the underlying tissues such as 
muscles, ligaments and internal organs, shielding it from 
exogenous molecules as well as from mechanical and 
radiation-induced injuries. The skin also plays a role in 
immunology and metabolism, regulates body 
temperature, serves as an excretory organ through 
sebaceous and sweat glands and contains sensory nerve 
endings for the perception of touch, temperature, pain 
and pressure. The skin varies in color, thickness and 
presence of nails, hairs and glands between the different 
regions of the body, although all types of skin have the 
same basic structure
4, 5
. 
The skin can be considered to have four distinct layers 
of tissue
6, 7
. 
1. Non-viable epidermis (stratum corneum) 
2. Viable epidermis 
3. Viable dermis 
4. Subcutaneous connective tissue (hypodermis) 
Non-viable epidermis (stratum corneum) 
Stratum corneum is the outer most layer of skin, which 
is the actual physical barrier to most substance that 
comes in contact with the skin. The stratum corneum is 
10 to 20 cell layer thick over most of the body. Each cell 
is a flat, plate-like structure  34-44 μm long, 25-36 μm 
wide, 0.5 to 0.20 μm thick - with a surface area of 750 to 
1200 μm2 stocked up to each other in brick like fashion. 
Stratum corneum consists of lipid (5-15%) including 
phospholipids, glycolsphingolipid, cholesterol sulfate 
and neutral lipid, protein (75-85%) which is mainly 
keratin. 
Viable epidermis 
This layer of the skin resides between the stratum 
corneum and the dermis and has a thickness ranging 
from 50- 100 μm. The structure of the cells in the viable 
epidermis is physiochemically similar to other living 
tissues. Cells are held together by tonofibrils. The 
density of this region is not much different than water. 
The water content is about 90%. 
Dermis 
Just beneath the viable epidermis is the dermis. It is a 
structural fibrin and very few cells are like it can be 
found histological in normal tissue. Dermis thickness 
range from 2000 to 3000 μm and consists of a matrix of 
loose connective tissue composed of fibrous protein 
embedded in an amorphous ground substance. 
Subcutaneous connective tissue 
The subcutaneous tissue or hypodermis is not actually 
considered a true part of the structured connective tissue 
is composed of loose textured, white, fibrous connective 
tissue containing blood and lymph vessels, secretory 
pores of the sweat gland and coetaneous nerves. Most 
investigators consider drug permeating through the skin 
enter the circulatory system before reaching the 
hypodermis, although the fatty tissue could serve as a 
depot of the drug. 
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Figure 1: structure of skin
12 
TRANSDERMAL DRUG DELIVERY 
SYSTEMS IN DRUG TARGETTING  
The transdermal drug delivery systems are used to target 
the drugs for purposes, described under
1
: 
1. Surface of skin: 
Surface of skin is targeted for locally acting substances 
like disinfectants, cosmetics, insect repellent etc. in 
which drug acts only on the surface of the skin and no 
penetration of drug or chemicals in the skin. 
2. Skin layers itself: 
The delivery of drug substances within the skin layers is 
also known as topical delivery and skin layers are 
targeted when disease or infection is present in skin 
itself e.g. microbial infection, inflammation of skin and 
neoplasias etc. 
3. Systemic Circulation: 
 It is considered as an alternative to oral and other 
conventional delivery routes for systemic delivery of 
drugs. The drug has to be permeated through the various 
skin layers. 
PATHWAYS OF DRUG ABSORPTION 
THROUGH THE SKIN 
The drug can be absorbed by various pathways through 
the skin depending on the physicochemical properties of 
the drug
9, 10, 11
. These are following; 
Transfollicular route  
Transfollicular route is the shortest pathway that drug 
has to follow to reach the systemic circulation that 
provides a large area for diffusion of drugs. Skin has 
various sweat glands, oil glands, hair follicles and pores 
opening to the outer surface of the skin via their ducts. 
These ducts offer a continuous channel across the 
stratum corneum for drug transport but various factors 
like secretion from glands, content and amount of 
secretion etc., affect the transport of drugs through this 
route.
1 
Transcellular route   
Drugs entering the skin via the transcellular route pass 
through corneocytes. Corneocytes, containing highly 
hydrated keratin, provide an aqueous environment for 
which hydrophilic drugs can pass. The cells are 
surrounded by a lipid envelope which connects the cells 
to the interstitial lipids. Separating keratinised skin cells 
are multiple lipid bilayers; there are estimated to be up 
to 20 such lamellae between each corneocyte . 
Therefore, the diffusion pathway for a drug via the 
transcellular route requires a number of partitioning and 
diffusion steps. After partitioning into and diffusing 
through the relatively aqueous corneocytes, the 
permeant must partition into the surrounding lipid 
envelope, and subsequently partition in and out of the 
multiple lipid bilayers separating corneocytes . 
Intercellular route 
As name indicates in intercellular pathway the drug 
diffuses through the continuous lipid matrix present 
between the cells. The barrier property of this route is 
due tortuous structure formed by corneocytes and the 
drug has to pass through the alternating lipid and 
aqueous domain by partitioning into the lipid bilayer 
and diffusing to the inner side. It has been found that 
water has to travel 50 times more by this route so; it is 
suitable mainly for uncharged lipophilic drugs.
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Figure 2: Pathways of permeation through skin 
PENETRATION ENHANCER 
Penetration enhancers are the substances used to 
increase permeation of skin mucosa. Penetration 
enhancer increases the absorption of penetrant through 
the skin which is also known as absorption promoter or 
absorption enhancers. Penetration enhancers used to 
increase the permeability of drug through skin
8
. 
The penetration enhancers may show their effect any 
one or combination of the following mechanisms.  
 By disrupting the structure of stratum corneum 
lipids.  
 By interacting with intercellular proteins.  
 By improving drug partitioning, co-enhancer or 
solvent into the stratum corneum.  
 Dissolution of drug in its vehicle.  
 Diffusion of drug from vehicle to surface of skin.  
Ideal characteristics of enhancers 
 An ideal penetration enhancer should have 
following properties. 
 The effect of enhancer on the skin should be 
reversible, and it should not damage the viable cells. 
 It should be pharmacologically inert, non-toxic, 
non-allergenic and non-irritating. 
 It should be compatible with the drug and other 
additives. 
 It should show their effect rapidly; with predictable 
and reproducible duration of effect. 
 It should have unidirectional enhancing effect; 
allowing the drug molecule to pass through the skin 
while preventing the loss of endogenous materials 
like body fluids, electrolytes etc. 
 It should be economical. 
 No single penetration enhancer possesses all these 
properties; however some penetration enhancers 
may possesses some of the above attributes 
FACTORS AFFECTING TRANSDERMAL 
PERMEABILITY 
Various factors are involved in controlling and rendering 
permeability of drugs through the skin. These factors 
may be drug related or skin physiology related. Not only 
a single reason is responsible in affecting the permeation 
of drugs but a number of factors are involved which are 
mutually dependent on each other and are classified 
below: 
1) Physiochemical properties of drug. 
2) Formulation characteristics. 
3) Skin physiology and pathology. 
1) Physicochemical properties of drug 
The various physicochemical properties of drug which 
can alter the absorption and diffusion of drug through 
the skin are: 
a. Size of drug molecules and molecular weight 
Size of drug molecules varies inversely to the 
penetration through the skin. Drug molecules larger than 
500 dalton creates problem in percutaneous transport. 
Greater the molecular weight smaller is the absorption. 
So size of drug molecules should not be so high that it 
creates problem in absorption
15
. 
b. Partition coefficient and solubility 
Drugs are either lipophilc or hydrophilic in nature. The 
partition co-efficient determine the solubility or 
diffusion of drug in lipids and aqueous systems. Drugs 
possessing both lipid and water solubility are suitable for 
percutaneous absorption as skin is made of lipid bilayer 
so drug should have some lipid solubility for absorption 
but at same time it should have some hydrophilicity to 
diffuse inside the skin in aqueous environment. So a 
drug candidate should have optimum partition co-
efficient. The partition coefficient of a drug can be 
altered by changing the solvent system or by chemical 
modification in the structure of the drug candidate 
without affecting its pharmacological activity of the 
drug
15
. 
c. Drug concentration 
The absorption of drugs through the skin is governed by 
passive diffusion. Drug moves according to 
concentration gradient i.e. from high concentration to 
low concentration. So the concentration of drug in the 
formulation applied over the skin determines the 
Jawale Neha                                                                                                           Journal of Drug Delivery & Therapeutics. 2017; 7(3):28-35                                     
ISSN: 2250-1177                                                                                [32]                                                                             CODEN (USA): JDDTAO 
diffusion rate across the skin. Higher the concentration 
more will be the permeation.
15 
d. pH conditions 
Most of the drugs are either acidic or basic in nature. So 
the pH of the drug molecule determines its ionization at 
skin surface. Unionized drugs or species have better 
absorption than ions or ionic species, so pH plays an 
important role in determining extent of penetration of 
drug
16
. 
2) Formulation characteristics 
The various formulation characteristics can also alter the 
permeation of drug molecule through the skin. These are 
as follows: 
a. Release rate of the drug 
The release of drug from the formulation is influenced 
by the affinity of the carrier for the drug in formulation 
and physiochemical properties of drug like solubility of 
drug in solvent and interfacial partitioning of drug from 
formulation to skin determines the release rate of the 
drug
16
. 
b. Ingredients of formulation 
Various excipients and polymers present in the 
formulation can affect either release of drug or 
permeation of drug through the skin by altering the 
physicochemical properties of drug or skin physiology
18
. 
c. Presence of permeation enhancers 
Permeation enhancers of different categories are used to 
increase the permeation of drug through the skin. These 
alter the integrity of the skin (physicochemical and 
physiological modification) temporarily and open the 
skin pores for absorption. Permeation enhancer may be 
chemical substance which act chemically or physical 
permeation enhancer which physically interact with the 
skin integrity
18
. 
3) Physiological and pathological condition of the 
skin 
The physiological and pathological conditions of the 
skin alter and affect the permeation of drug candidate 
through the skin by changing the properties of the skin 
17
. 
a. Hydration of skin 
Hydration of the skin causes the swelling of stratum 
corneum of the skin and provides some fluidity to the 
skin. Hydration also increases the permeant solubility 
and partitioning from vehicle to the membrane. So the 
permeation of drug molecules occurs easily through the 
hydrated skin
17
. 
b. Skin temperature 
On increasing the temperature of the skin the 
percutaneous absorption of the drug increases due to 
fluidization of lipids and vasodilation of the blood 
vessels which are in contact with the skin so increase in 
blood flow to the skin increases the absorption through 
the skin. 
c. Skin age 
It is assumed that skin of young and elderly are more 
permeable than middle aged persons. In premature 
infants stratum corneum is absent and children are more 
susceptible to toxic effects of drugs through the skin. 
d. Blood flow 
Changes in peripheral circulation do not affect 
transdermal absorption butan increase in blood flow 
increase the concentration gradient across the skin and 
reduces the total time of residence of the drug molecules 
in the dermis by continuously removing it. 
e. Pathology of the skin 
Disease of the skin and any injury to the skin causes the 
rupturing of the lipid layers of the stratum corneum 
which alters the skin penetration of drugs. Pathogens 
cause the disruption of skin layers by digesting them and 
can create pores in the skin so the integrity of the skin 
changes in both pathological conditions and in injury
17
. 
f. Regional Site of skin 
The skin differs in anatomical features such as thickness 
of stratum corneum, number of hair follicles and number 
of sweat glands per unit surface area. This difference 
may exist from site to site, person to person and species 
to species. So in all cases percutaneous absorption 
differs from one another
18
. 
g. Skin flora and enzymes  
Various metabolizing enzymes and metabolizing 
microbes are present in the skin which metabolizes the 
drugs passing through the skin. Only a few drug 
candidates are there which reaches in active form in the 
circulation otherwise drugs are metabolized to various 
extents in the skin. E.g., 95% of the testosterone 
absorbed gets metabolized in the skin
18
. 
PHYSICAL APPROACH TO 
TRANSDERMAL DRUG DELIVERY 
SYSTEM 
Physical transdermal delivery enhancing methods 
increase the transdermal delivery by using an external 
energy as a driving force. Active methods make possible 
the permeation of larger molecules which can’t be 
permeated otherwise. Various physical methods used for 
enhancing transdermal delivery are discussed here 
below; 
1. Iontophoresis 
It was developed to facilitate the delivery of ionized 
solute, with inherently low partition coefficients due to 
their charged states, across tissue membrane The 
principle of iontophoresis technique is based on that the 
like charges repels each other and opposite charge 
attract. Thus during iontophoresis, if delivery of 
positively charged drug, the charged drug is dissolved in 
the electrolyte surroundings the electrode of similar 
polarity, i.e. anode. An application of electromotive 
force the drug is repelled and moves across the stratum 
corneum towards the cathode, which is placed elsewhere 
on the body 
12,19,20,25
 The drug permeation is caused by 
any one or combination of following mechanisms.  
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 Electro-repulsion (for similar charged solutes)  
 Electro-osmosis (for uncharged solutes)  
 Electro-perturbation (for both charged and 
uncharged solutes) 
 
 
Figure 3: Diagrammatic representation of 
Iontophoresis with modification.
14 
2. Sonophoresis 
It is the application of ultrasound to enhance the 
percutaneous drug delivery. In this method the drug is 
mixed with a coupling agent in the form of gel, cream or 
ointment. The coupling agent acts as a medium for the 
transfer of phonophoretic energy from the device to the 
skin. Sonophoresis causes disruption of stratum corneum 
by cavitation, microscreening and heat sensitization 
23,24
. 
This involves rupturing the lipids present in stratum 
cornea, which allows the medicament to permeate via 
biological barrier 
26
. It uses low frequency ultrasound 
(55 kHz) for an average duration of 15 seconds to 
enhance skin permeability. 
 
 
Figure 4: Diagramatic presentation of Sonophoresis
12 
 
3. Eletroporation 
Electroporation is the phenomenon in which cell 
membrane permeability to ions and macromolecules is 
increased by exposing the cell to short high electric field 
pulses. The mechanism for electroporation by two 
pathways, through pores formed in the multiple lipid 
bilayer connecting corneocytes and through appendage 
cells. The efficacy of transport of drug depends on the 
electrical parameters and the physicochemical properties 
of drugs.  In electroporation the transdermal delivery of 
the drug molecule is increased by the application of a 
high voltage (100 volts) in the form of direct currect 
(DC) 
13, 28, 29.
 
4. Magnetophoresis 
This method involves the application of a magnetic field 
which acts as an external driving force to enhance the 
diffusion of a diamagnetic solute across the skin. Skin 
exposure to a magnetic field might also induce structural 
alterations that could contribute to an increase in 
permeability.  
This technique can be used for the permeation of 
diamagnetic molecules. This method has been 
implemented for the transdermal delivery of benzoic 
acid. The diffusion flux is in direct proportion with 
intensity of the applied magnetic field. 
Magnetoliposomes consist of magnetic Nanoparticles 
wrapped by a phospholipids bilayer which can be 
successfully applied for drug delivery systems, magnetic 
resonance imaging markers for cancer diagnosis, and 
thermal cancer therapy 
30,31,32
. 
 
Figure 5: Diagrammatic presentation of 
Electroporation
31 
5. Microneedles  
Micrneedles technique may also be called as 
microscopic projection. As the name indiactes the 
device contains microprojections which are arranged in 
array.  
The device as described in the patent consists of a drug 
reservoir and a plurality of projections extending from 
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the reservoir. These microneedles of length 50 to 110 
mm will penetrate the stratum corneum and epidermis to 
deliver the drug from the reservoir. The reservoir may 
contain drug, solution of drug, gel, or solid particulates, 
and the various embodiments of the invention include 
the use of a membrane to separate the drug from the skin 
and control release of the drug from its reservoir 
32-34
. 
 
 
Figure 6:  Microneedles based drug patch.
14 
 
6. Radio – frequency 
Radio frequency involves the exposure of skin to high 
frequency alternating current (~100 kHz), resulting in 
the formation of heat-induced microchannels in the 
membrane in the same way as when laser radiation is 
employed. The rate of drug delivery is controlled by the 
number and depth of the microchannels formed by the 
device, which is dependent on the properties of the 
microelectrodes used in the device.  
 
Figure 7: Diagrammatic presentation of radio-
frequency for transdermal 
The microneedle array is attached to the electronic 
device and placed in contact with the skin to facilitate 
the formation of the microchannels. Treatment duration 
takes less than a second, with a feedback mechanism 
incorporated within the electronic control providing a 
signal when the microchannels have been created, so as 
to ensure reproducibility of action. The drug patch is 
then placed on the treated area.  It has been 
demonstrated from in vivo studies that plasma level of 
granisetron HCl after 12 hours was 30 times greater 
when exposed to radio frequency than the level recorded 
for untreated skin after 24 hours. In the same research 
permeability of diclofenac through the skin was also 
observed 
14, 36
. 
CONCLUSION 
In order to overcome the skin’s barrier function, the 
physical enhancements for the transdermal drugs have 
been developed. Physical techniques have made the 
penetration enhancer more effective. These approaches 
are very useful for the drugs having low permeable 
property, low soluble drugs and for the drugs having 
short biological half life. To overcome the problems of 
other techniques physical techniques has been found to 
be more effective as well as acceptable. 
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